These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6330425)

  • 21. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.
    Siwek M; Dudek D; Paul IA; Sowa-Kućma M; Zieba A; Popik P; Pilc A; Nowak G
    J Affect Disord; 2009 Nov; 118(1-3):187-95. PubMed ID: 19278731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pilot trial of the prevention of the increase in electrical taste thresholds by zinc containing fluid infusion during chemotherapy to treat primary lung cancer.
    Yamagata T; Nakamura Y; Yamagata Y; Nakanishi M; Matsunaga K; Nakanishi H; Nishimoto T; Minakata Y; Mune M; Yukawa S
    J Exp Clin Cancer Res; 2003 Dec; 22(4):557-63. PubMed ID: 15053297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zinc deficiency: a reversible complication of uremia.
    Mahajan SK; Prasad AS; Rabbani P; Briggs WA; McDonald FD
    Am J Clin Nutr; 1982 Dec; 36(6):1177-83. PubMed ID: 6890761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
    Cohen SB; Emery P; Greenwald MW; Dougados M; Furie RA; Genovese MC; Keystone EC; Loveless JE; Burmester GR; Cravets MW; Hessey EW; Shaw T; Totoritis MC;
    Arthritis Rheum; 2006 Sep; 54(9):2793-806. PubMed ID: 16947627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of zinc therapy on uremic hypogonadism: a double blind study.
    Mahajan SK; Abbasi AA; Prasad AS; Briggs WA; McDonald FD
    Proc Clin Dial Transplant Forum; 1979; 9():260-1. PubMed ID: 121815
    [No Abstract]   [Full Text] [Related]  

  • 26. Middle molecular weight substances and uremic polyneuropathy.
    Dukanović L; Petrović J; Potić J
    Acta Med Iugosl; 1990; 44(2):117-28. PubMed ID: 2162129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nerve conduction studies and prediction of mortality in hemodialysis patients.
    Stosovic M; Nikolic A; Stanojevic M; Simic-Ogrizovic S; Radovic M; Jovanovic D; Popovic Z; Trikic R; Djukanovic L
    Ren Fail; 2008; 30(7):695-9. PubMed ID: 18704818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic neuropathy and zinc therapy.
    Hayee MA; Mohammad QD; Haque A
    Bangladesh Med Res Counc Bull; 2005 Aug; 31(2):62-7. PubMed ID: 16967811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study.
    Nowak G; Siwek M; Dudek D; Zieba A; Pilc A
    Pol J Pharmacol; 2003; 55(6):1143-7. PubMed ID: 14730113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of zinc supplements on the nutritional status of patients undergoing continuous ambulatory peritoneal dialysis].
    Munguía C; Paniagua R; Avila-Díaz M; Nava-Hernández J; Rodríguez E; Ventura Mde J; Amato D
    Rev Invest Clin; 2003; 55(5):519-27. PubMed ID: 14968473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial.
    Kaufmann P; Engelstad K; Wei Y; Jhung S; Sano MC; Shungu DC; Millar WS; Hong X; Gooch CL; Mao X; Pascual JM; Hirano M; Stacpoole PW; DiMauro S; De Vivo DC
    Neurology; 2006 Feb; 66(3):324-30. PubMed ID: 16476929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.
    Davis ID; Kiers L; MacGregor L; Quinn M; Arezzo J; Green M; Rosenthal M; Chia M; Michael M; Bartley P; Harrison L; Daly M
    Clin Cancer Res; 2005 Mar; 11(5):1890-8. PubMed ID: 15756015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of uremic hypogeusia by zinc.
    Mahajan SK; Prasad AS; Lambujon J; Abbasi AA; Briggs WA; McDonald FD
    Trans Am Soc Artif Intern Organs; 1979; 25():443-8. PubMed ID: 524620
    [No Abstract]   [Full Text] [Related]  

  • 36. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
    Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
    Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subclinical peripheral neuropathy in stable middle-aged patients with chronic obstructive pulmonary disease.
    Agrawal D; Vohra R; Gupta PP; Sood S
    Singapore Med J; 2007 Oct; 48(10):887-94. PubMed ID: 17909671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients.
    Canavese C; Grill A; Decostanzi E; Maddalena E; Barbieri S; Martina G; Fop F; Buglione E; Grechi D; David O; Saitta M; Piccoli G
    Clin Nephrol; 2000 Jan; 53(1):42-7. PubMed ID: 10661481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials.
    Tesfaye S; Tandan R; Bastyr EJ; Kles KA; Skljarevski V; Price KL;
    Diabetes Care; 2007 Oct; 30(10):2626-32. PubMed ID: 17623822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus.
    Chen YC; Chiu WT; Wu MS
    Am J Kidney Dis; 2006 Jul; 48(1):69-76. PubMed ID: 16797388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.